Type:
Presentación Electrónica Educativa
Authors:
A. Alvarez-Cofiño Tuñón1, E. Montes Pérez1, L. Raposo1, N. Fernandez Garcia2, B. Escobar Mallada1, T. Díaz Sánchez1; 1Gijón/ES, 2Oviedo/ES
DOI:
10.1594/seram2014/S-0105
Bibliografía
Van Assche G,
Herrmann KA,
Louis E,
Everett SM,
Colombel JF,
Rahier JF,
Vanbeckevoort D,
Meunier P,
Tolan D,
Ernst O,
Rutgeerts P,
Vermeire S,
Aerden I, Oortwijn A,
Ochsenkühn T.
Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease.
J Crohns Colitis.
2013 Dec 15;7(12):950-7.
Rimola J,
Rodriguez S,
Garcia-Bosch O,
et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn’s disease. Gut 2009;58:1113–20.
Maccioni F,
Bruni A,
Viscido A,
et al.
MR imaging in patients with Crohn disease: value of T2-versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent.
Radiology 2006;238(2):517–30.
Yacoub JH,
Oto A.
New magnetic resonance imaging modalities for Crohn disease.
Magn Reson Imaging Clin N Am.
2014 Feb;22(1):35-50.
Buisson A,
Joubert A,
Montoriol PF,
Da Ines D,
Hordonneau C,
Pereira B,
Garcier JM,
Bommelaer G,
Petitcolin V.
Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn's disease.
Aliment Pharmacol Ther.
2013 Mar;37(5):537-45.